In agreement with this possibility, bone marrow-derived mesenchymal stem cells have been shown to stimulate de novo LOX production in MDA-MB-231 and MCF7 BC cell lines, which correlated with enhanced lung and bone metastases in a mouse model [57]. This evidence concerns the gene LOX and breast cancer.